OcellO B.V.

OcellO B.V. is located in Leiden, Netherlands on BioPartner Center, J.H. Oortweg 21. OcellO B.V. is rated 3 out of 5 in the category biotechnology company in Netherlands. OcellO is a contract research organization specialized in the discovery and preclinical validation of new drug candidates. We excel in in vitro 3D cell culture models and innovative high throughput imaging technologies. Our models are selected for clinically relevant, ‘near-vivo’ properties and consist of patient-derived cells and patient-derived xenografts (PDX models) grown in 3D as organoids, tumoroids or microtissues. We offera broad collection of human tissue models, including most solid tumor types, immune-oncology, cystopathies (incl. polycystic kidney disease and cystic fibrosis) and Inflammatory Bowel Disease. Functional read-outs are established by image analysis using OcellO’s unique high throughput, high content screening platform. Features include cell proliferation, apoptosis, tumoroid size, organoid swelling, T cell infiltration, network formation, lumen formation and others. The high throughput format of our platform has proven ideal for in-depth functional profiling of a single compound or for screening of compound libraries in a single 3D disease model. OcellO would like to meet with companies (typically drug developers) that are interested in 1. validation in 3D cell/organoid models of their drug candidate(s) 2. screening services to discover new drug candidates in 3D cell models Please visit our site at OcellO.nl for more information and contact.